We hypothesized that MC4R inhibition by the melanocortin receptor antagonist ML can reduce tumor proliferation of colorectal cancer cells and of anaplastic thyroid cancer cells and synergize with standard chemotherapy agents. This evidence concerns the gene MC4R and neoplasm.